From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Archives of Toxicology

• Publication date

  2015-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00204-015-1461-5PMID 25632846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma

  2015cited by this paper
• A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.

  2014cited by this paper
• Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma.

  2014cited by this paper
• Sirukumab: a novel therapy for lupus nephritis?

  2014cited by this paper
• Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.

  2014cited by this paper
• Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

  2014cited by this paper
• Systemic Administration of a Cyclic Signal Transducer and Activator of Transcription 3 (STAT3) Decoy Oligonucleotide Inhibits Tumor Growth without Inducing Toxicological Effects

  2014cited by this paper
• IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab

  2014cited by this paper
• Discovery and characterization of olokizumab

  2014cited by this paper
• Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production

  2014influential reference
• IL-6 biology: implications for clinical targeting in rheumatic disease

  2014cited by this paper
• IL-6 in inflammation, immunity, and disease.

  2014cited by this paper
• A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors

  2014cited by this paper
• Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors

  2014cited by this paper
• CD4+ T Cells

  2014cited by this paper
• IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.

  2014cited by this paper
• Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy

  2014cited by this paper
• Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study

  2014cited by this paper
• A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases

  2013influential reference
• Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study

  2013cited by this paper
• A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer

  2013cited by this paper
• Targeting the tumor microenvironment

  2013cited by this paper
• Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.

  2013cited by this paper
• A phase 2 multicentre study of siltuximab, an anti‐interleukin‐6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

  2013cited by this paper
• Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial

  2013cited by this paper
• OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.

  2013cited by this paper
• Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

  2013cited by this paper
• gp130: a promising drug target for cancer therapy

  2013influential reference
• Therapeutic targeting of the interleukin-6 receptor.

  2012cited by this paper
• First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

  2012cited by this paper
• Therapeutic Blockade of Interleukin‐6 in Chronic Inflammatory Disease

  2012cited by this paper
• Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis

  2012cited by this paper
• A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate

  2012cited by this paper
• The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma.

  2012cited by this paper
• Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer.

  2012cited by this paper
• Th17 cells in inflammation.

  2011cited by this paper
• Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

  2011cited by this paper
• IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.

  2011cited by this paper
• A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

  2011cited by this paper
• Identification of IL6R and chromosome 11q13.5 as risk loci for asthma.

  2011cited by this paper
• Induction of tolerogenic lung CD4+ T cells by local treatment with a pSTAT-3 and pSTAT-5 inhibitor ameliorated experimental allergic asthma.

  2011cited by this paper
• The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells

  2011cited by this paper
• Comparative analysis of the effects of anti‐IL‐6 receptor mAb and anti‐TNF mAb treatment on CD4+ T‐cell responses in murine colitis

  2011cited by this paper
• Anti-IL-6 receptor antibody suppressed T cell activation by inhibiting IL-2 production and inducing regulatory T cells.

  2010cited by this paper
• VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer

  2010cited by this paper
• IL‐6: Regulator of Treg/Th17 balance

  2010cited by this paper
• The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients

  2010cited by this paper
• Sputum IL-6 concentrations in severe asthma and its relationship with FEV1

  2010cited by this paper
• Tocilizumab for the treatment of rheumatoid arthritis

  2010cited by this paper
• Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function

  2010cited by this paper
• Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity

  2010cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis

  2009cited by this paper
• The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells

  2009cited by this paper
• Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.

  2009cited by this paper
• Properties and origin of human Th17 cells.

  2009cited by this paper
• Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule

  2009cited by this paper
• gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

  2009cited by this paper
• Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model

  2009cited by this paper
• Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase

  2009cited by this paper
• Arthritis and pneumonitis produced by the same T cell clones from mice with spontaneous autoimmune arthritis.

  2008cited by this paper
• A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)

  2008cited by this paper
• Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

  2008cited by this paper
• The transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis

  2008influential reference
• Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

  2008cited by this paper
• The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.

  2008cited by this paper
• Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.

  2008cited by this paper
• Regulation of IL-17 in Human CCR6+ Effector Memory T Cells1

  2008cited by this paper
• Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.

  2008cited by this paper
• Lower Airway Disease in Asthmatics with and without Rhinitis

  2008cited by this paper
• The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.

  2008cited by this paper
• Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.

  2007cited by this paper
• Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25− T Cells1

  2007cited by this paper
• Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels.

  2007cited by this paper
• Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon

  2007cited by this paper
• Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

  2007cited by this paper
• A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects

  2007cited by this paper
• Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.

  2007cited by this paper
• Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

  2006cited by this paper
• Transforming growth factor-beta induces development of the T(H)17 lineage.

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis.

  2006cited by this paper
• Interleukin-6 trans-signaling in inflammatory bowel disease.

  2006cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

  2006cited by this paper
• A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  2005cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

  2005cited by this paper
• The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

  2005cited by this paper
• Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

  2005cited by this paper
• Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis.

  2005cited by this paper
• Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

  2005cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

  2005cited by this paper
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody

  2005cited by this paper
• Colitis in mice lacking the common cytokine receptor gamma chain is mediated by IL-6-producing CD4+ T cells.

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

  2005cited by this paper
• Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma.

  2004cited by this paper
• Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6‐deficient mice following chronic exposure to aerosolized antigen

  2004cited by this paper
• Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004influential reference

• Immunomodulatory Effects of Launaea sarmentosa Extract on Cyclophosphamide-Induced Immunosuppressed Mice

  2025cites this paper
• Tissue and systemic inflammation in dystrophic epidermolysis bullosa: a systematic review and meta-analysis

  2025cites this paper
• Clinical and biological impact of conversion on outcomes of minimally invasive liver surgery: a multimodal analysis.

  2025cites this paper
• Analysis of the Effects of IL-6 -572 C/G, CRP -757 A/G, and CRP -717 T/C Gene Polymorphisms; IL-6 Levels; and CRP Levels on Chronic Periodontitis in Coronary Artery Disease in Indonesia

  2023cites this paper
• Evaluation of You-Gui-Wan critical compounds inhibiting ALOX-5 and HDC gene expression in RBL-2H3 cells using a fractional factorial design.

  2023cites this paper
• Expression quantitative trait loci for ETV4 and MEOX1 are associated with adult asthma in Japanese populations

  2021cites this paper
• Circulating miRNA expression over the course of colorectal cancer treatment

  2021cites this paper
• Inhibition of inflammation-induced injury and cell migration by coelonin and militarine in PM2.5-exposed human lung alveolar epithelial A549 cells.

  2021cites this paper
• Micro-RNA 155 - On the Crosspoint of Inflammation and Carcinogenesis

  2021cites this paper
• Salivary cytokine profile in patients with oral lichen planus

  2021cites this paper
• Multiomic analysis of cytokines in immuno-oncology

  2020cites this paper
• Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine

  2020cites this paper
• Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression

  2020cites this paper
• Untersuchung des Einflusses von autochthonen potentiell pathogenen Bakterien und Laktobazillen auf bovine Endometriumszellen in vitro

  2020cites this paper
• Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles

  2019cites this paper
• The role of cytokines in the regulation of NK cells in the tumor environment.

  2019cites this paper
• Lectin isolated from Bothrops jararacussu venom induces IL‐10 release by TCD4+ cells and TNF‐α release by monocytes and natural killer cells

  2019cites this paper
• Interleukin-6 Rescues Lymphocyte from Apoptosis and Exhaustion Induced by Chronic Hepatitis C Virus Infection

  2018cites this paper
• Maternal Hypermethioninemia Affects Neurons Number, Neurotrophins Levels, Energy Metabolism, and Na+,K+-ATPase Expression/Content in Brain of Rat Offspring

  2018cites this paper
• Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies.

  2018cites this paper
• IL‐6 pathway upregulation in subgroup of severe asthma is associated with neutrophilia and poor lung function

  2018cites this paper
• Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes.

  2018cites this paper
• IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.

  2018cites this paper
• Impact of Toxin-Specific Antibodies on the Adjuvanticity and Inflammatory Effects Induced by Parenterally Administered Escherichia coli heat-Labile Toxin

  2018cites this paper
• Cytokines concentrations in serum samples from allergic children-Multiple analysis to define biomarkers for better diagnosis of allergic inflammatory process.

  2018cites this paper
• 2′,4-Dihydroxy-3′,4′,6′-trimethoxychalcone from Chromolaena odorata possesses anti-inflammatory effects via inhibition of NF-κB and p38 MAPK in lipopolysaccharide-activated RAW 264.7 macrophages

  2018cites this paper
• Mechanisms and effects of luteolin on inflammatory polarization of mouse macrophages

  2018cites this paper
• Immunomodulatorische Funktion von Interleukin-37 in der Asthma-Pathogenese

  2017cites this paper
• Association of Gene Polymorphisms in Interleukin 6 in Infantile Bronchial Asthma

  2017cites this paper
• Persistent elevation of serum interleukin-6 and serum amyloid A levels in patients with recessive dystrophic epidermolysis bullosa

  2017cites this paper
• Association of Gene Polymorphisms in Interleukin 6 in Infantile Bronchial Asthma.

  2017cites this paper
• Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical Implications

  2017cites this paper
• World Trade Center (WTC) dust exposure in mice is associated with inflammation, oxidative stress and epigenetic changes in the lung.

  2017cites this paper
• Alterações bioquímicas, moleculares, histológicas e comportamentais na prole de ratas Wistar submetidas à hipermetioninemia gestacional

  2017cites this paper
• Effects of Concurrent Exposure of Diesel Exhaust Particles and House Dust Mite on the Development of Allergen-Induced Airways Inflammation

  2016cites this paper
• Anti-Warburg effect of rosmarinic acid via miR-155 in colorectal carcinoma cells

  2016cites this paper
• Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis

  2016cites this paper
• Immunoinflammatory diseases of the central nervous system – the tale of two cytokines

  2016cites this paper
• Thyroid Cells Exposed to Simulated Microgravity Conditions – Comparison of the Fast Rotating Clinostat and the Random Positioning Machine

  2016cites this paper
• Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract

  2016cites this paper
• Fructus sophorae attenuates secretion of proinflammatory mediators and cytokines through the modulation of NF-κB and MAPK signaling pathways in LPS-stimulated RAW 264.7 macrophages.

  2016cites this paper
• Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients

  2016cites this paper
• Alleviation of collagen-induced arthritis by the benzoxathiole derivative BOT-4-one in mice: Implication of the Th1- and Th17-cell-mediated immune responses.

  2016cites this paper
• THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) Investigation of UVB-induced cellular mechanisms in human keratinocytes using a novel approach of delivering in vitro synthesized mRNA encoding cyclobutane pyrimidine dimer-specific photolyase by Gábor Boros UNIVERSITY OF DEBRECEN DOCTORAL SCHOOL

  2015cites this paper
• Thyroid Cells Exposed to Simulated Microgravity Conditions – Comparison of the Fast Rotating Clinostat and the Random Positioning Machine

  2015cites this paper
• Influence of phenotype conversion of epicardial adipocytes on the coronary atherosclerosis and its potential molecular mechanism.

  2015cites this paper
• SIRT2 - JAK1 Interaction Decreases IL-6 Induced Inflammatory Response in Cancer Cells

  2015cites this paper